# Safety and Efficacy of J147 in Acute Ischemic Stroke

Study · id `cardio:ct-nct07430917` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07430917](<https://clinicaltrials.gov/study/NCT07430917>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07430917

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 196 participants.

## Technical summary

Registry record NCT07430917. Randomized; quadruple masking; primary purpose treatment. Start 2026-07-22 (actual); primary completion 2028-03-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 196 participants (planned count; ClinicalTrials.gov record NCT07430917, source copy `cardio:ctgov-nct07430917-2026-08-24`, retrieved 2026-10-26)
- Started: 2026-07-22 (actual) (ClinicalTrials.gov record NCT07430917, source copy `cardio:ctgov-nct07430917-2026-08-24`, retrieved 2026-10-26)
- Primary completion: 2028-03-01 (anticipated) (ClinicalTrials.gov record NCT07430917, source copy `cardio:ctgov-nct07430917-2026-08-24`, retrieved 2026-10-26)
- Completion: 2028-07-01 (anticipated) (ClinicalTrials.gov record NCT07430917, source copy `cardio:ctgov-nct07430917-2026-08-24`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT07430917, source copy `cardio:ctgov-nct07430917-2026-08-24`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07430917-2026-08-24`, retrieved 2026-10-26)

## The registry's words

- Brief title: Safety and Efficacy of J147 in Acute Ischemic Stroke
- Acronym: JUMPSTART
- Condition: Acute Ischemic Stroke
- Intervention (Drug): J147 Emulsion for Injection
- Intervention (Other): Placebo
- Lead sponsor: Abrexa Pharmaceuticals, Inc.
- Lead sponsor class: INDUSTRY
- Collaborator: IQVIA RDS Inc.
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)

## Provenance

Content hash: ad2e7903374e1e8f752c86d8bef7a2ac5bb83760b17318220c076d69ea5ea769
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
